XTANT MEDICAL HOLDINGS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- XTANT MEDICAL HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $4.46M, a 68.20% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $14.01M, a 168.15% increase year-over-year.
- XTANT MEDICAL HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $5.22M.
- XTANT MEDICAL HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $12.83M.
- XTANT MEDICAL HOLDINGS, INC. stock issued during period, value, new issues for fiscal 2024 was $4.46M, a 68.20% decline from fiscal 2023.
- XTANT MEDICAL HOLDINGS, INC. stock issued during period, value, new issues for fiscal 2023 was $14.01M, a 82.41% increase from fiscal 2022.
- XTANT MEDICAL HOLDINGS, INC. stock issued during period, value, new issues for fiscal 2022 was $7.68M, a 40.14% decline from fiscal 2021.
- XTANT MEDICAL HOLDINGS, INC. stock issued during period, value, new issues for fiscal 2021 was $12.83M, a 1969.52% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $4.46M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $4.46M 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $14.01M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $14.01M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $7.68M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $5.22M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $12.83M 10-K · filed 2023-03-07 | |
| 2021-03-31 | $12.83M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $620.00K 10-K · filed 2022-03-08 | |
| 2018-12-31 | -$101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $79.10M 10-K · filed 2020-03-05 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | |
| 2018-06-30 | $1.00K 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $79.20M 10-Q · filed 2019-05-15 | |
| 2016-12-31 | $2.56M 10-K · filed 2018-04-05 | |
| 2015-12-31 | $515.39K 10-K · filed 2017-03-29 | |
| 2014-12-31 | $5.87M 10-K · filed 2016-03-24 | |
| 2013-12-31 | $4.45M 10-K · filed 2015-03-18 | |
| 2013-06-30 | $8.51M 10-Q · filed 2013-08-13 | |
| 2012-03-31 | $3.90M 10-Q · filed 2013-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |